Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Hong Yan

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Thoracic Cancer|July 21, 2020
Three-dimensional printed navigational template for localizing small pulmonary nodules: A case-controlled studyRui Fu, Yun-Fei Chai, Jia-Tao Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2014
Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitorZhu Zeng, Hong-hong Yan, Xu-chao Zhang, et al.
Thoracic Cancer|September 7, 2018
Prophylactic air-extraction strategy after thoracoscopic wedge resectionJia-Tao Zhang, Yi-Chun Tang, Jun-Tao Lin, et al.
The Annals of Thoracic Surgery|January 12, 2020
Randomized Trial of an Improved Drainage Strategy Versus Routine Chest Tube After Lung Wedge ResectionJia-Tao Zhang, Song Dong, Xiang-Peng Chu, et al.
Journal of Hematology & Oncology|September 14, 2016
Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trialQing Zhou, Jin-Ji Yang, Zhi-Hong Chen, et al.
Annals of Surgical Oncology|December 5, 2012
KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapyJi-lin Guan, Wen-zhao Zhong, She-juan An, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2014
A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)Qing Zhou, Cai-cun Zhou, Gong-yan Chen, et al.
Clinical Lung Cancer|July 22, 2014
Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancerYan-yan He, Xu-chao Zhang, Jin-ji Yang, et al.
Medical Oncology (Northwood, London, England)|April 5, 2011
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapyShe-Juan An, Yi-Sheng Huang, Zhi-Hong Chen, et al.
The International Journal of Biological Markers|March 7, 2015
Single nucleotide polymorphisms in VTI1A gene contribute to the susceptibility of Chinese population to non-small cell lung cancerWen-Mei Su, Zhi-Hong Chen, Xu-Chao Zhang, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Thoracic Cancer|July 21, 2020
Three-dimensional printed navigational template for localizing small pulmonary nodules: A case-controlled studyRui Fu, Yun-Fei Chai, Jia-Tao Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2014
Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitorZhu Zeng, Hong-hong Yan, Xu-chao Zhang, et al.
Thoracic Cancer|September 7, 2018
Prophylactic air-extraction strategy after thoracoscopic wedge resectionJia-Tao Zhang, Yi-Chun Tang, Jun-Tao Lin, et al.
The Annals of Thoracic Surgery|January 12, 2020
Randomized Trial of an Improved Drainage Strategy Versus Routine Chest Tube After Lung Wedge ResectionJia-Tao Zhang, Song Dong, Xiang-Peng Chu, et al.
Journal of Hematology & Oncology|September 14, 2016
Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trialQing Zhou, Jin-Ji Yang, Zhi-Hong Chen, et al.
Annals of Surgical Oncology|December 5, 2012
KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapyJi-lin Guan, Wen-zhao Zhong, She-juan An, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2014
A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)Qing Zhou, Cai-cun Zhou, Gong-yan Chen, et al.
Clinical Lung Cancer|July 22, 2014
Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancerYan-yan He, Xu-chao Zhang, Jin-ji Yang, et al.
Medical Oncology (Northwood, London, England)|April 5, 2011
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapyShe-Juan An, Yi-Sheng Huang, Zhi-Hong Chen, et al.
The International Journal of Biological Markers|March 7, 2015
Single nucleotide polymorphisms in VTI1A gene contribute to the susceptibility of Chinese population to non-small cell lung cancerWen-Mei Su, Zhi-Hong Chen, Xu-Chao Zhang, et al.
Pageof 12